The term Cerebral Palsy refers to the outcomes of an early, within the first or second year of life, acute brain injury characterized by neuromotor symptoms: paralysis, spasticity, chorea (sudden, rapid, involuntary movements, especially in the face and limbs), athetosis (continuous, involuntary movements of hands, face, and tongue), ataxia (lack of coordination of voluntary muscle movements). Cerebral Palsy represents the most frequent neuromuscular pathologies in pediatric age, with causes being prenatal, perinatal, or postnatal. The use of neonatal intensive therapies has undoubtedly increased the survival of children with severe malformations or cerebral distress caused by deficient blood flow (ischemia), thus expanding the number of individuals with cerebral palsy. Over time, the need for rehabilitative and surgical treatments to improve these patients' deficits has emerged. Surgical treatment aims to prevent osteoarticular deformities, improve motor functionality, and facilitate the caregiving tasks of healthcare providers and families.
Spasticity is a disruptive element for motor coordination, sitting and lying postures, leading to the development of distorted attitudes, joint rigidity, and orthopedic deformities.
The incidence of deformities is closely linked to the severity of the neurological condition; hence, early screening and treatment become fundamental.